Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. T. N. Lee, Y. Ling, K. Sheares, J. Pepke-Zaba, A. Peacock, M. Johnson (Glasgow, Cambridge, United Kingdom). Predicting survival in pulmonary hypertension in the United Kingdom: Comparison of prognostic equations. Eur Respir J 2011; 38: Suppl. 55, 4915

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: Short term improvement in 6 minute walk distance predicts long term survival in incident idiopathic pulmonary arterial hypertension. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Late-breaking abstract: Demographic trends and changes In long term outcome of incident idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension between 2001 to 2009. Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension Year: 2011 Idiopathic pulmonary fibrosis mortality in the United States: is there any evidence of occupational risk? Source: Eur Respir J 2005; 26: Suppl. 49, 702s Year: 2005 Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020 Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017 Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016 Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Validation of a prognostic score for pulmonary embolism short-term mortality Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Surrogate markers of right ventricular adaptation better predict long-term survival in patients with PAH than traditional prognostic variables Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry Source: Eur Respir J, 53 (2) 1801677; 10.1183/13993003.01677-2018 Year: 2019 Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017 Year: 2018 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model Source: Eur Respir J 2016; 48: 780-786 Year: 2016 Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Source: Eur Respir J 2010; 35: 1079-1087 Year: 2010 Use of prognostic indicators to identify patients with end stage COPD: A survey of South-West (SW) England clinicians Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Pulmonary arterial hypertension-related morbidity is prognostic for survival: insights from the SERAPHIN and GRIPHON studies Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017